Juan Pablo Ospina Botero, MD

Medical Oncology
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
Make an appointmentCall 215-615-5858
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Neurology

My education and training

  • Medical School: Universidad De Los Andes Colombia
  • Residency: University of Chicago Medical Center
  • Fellowship: Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Ospina Botero is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Lanman TA, Youssef G, Huang R, Rahman R, DeSalvo M, Flood T, Hassanzadeh E, Lang M, Lauer J, Potter C, Jiao A, Pan I, Cahill DP, Lan Z, Ospina JP, Nakhate V, Stec NE, Shi D, Bi WL, McBrayer SK, Arrillaga-Romany I, Lee EQ, Chukwueke UN, Nayak L, Forst DA, Gerstner ER, Jordan JT, Dietrich J, Miller J, Batchelor TT, Reardon DA, Wen PY, Gonzalez Castro LN Ivosidenib for the treatment of IDH1-mutant glioma, grades 2-4: Tolerability, predictors of response, and outcomes , Neurooncol Adv, 7(1): 2024,vdae227

Ospina JP, Wen PY Medical and neurologic management of brain tumor patients , Curr Opin Neurol, 37(6): 2024,657-665

Fortunato J, Ospina JP, Park DM Chordoma , Neuro-Oncology. MedLink Neurology: 2024

Ospina JP, Viera M, Wetzel E, Cahill D, Gerstner ER, Miller JJ Impact of resection at time of first recurrence in WHO Grade 2 IDH-mutant gliomas , Society for NeuroOncology Annual Meeting 2024: 2024

Ospina JP, Boss S, Javed A Tractrography for Evaluation of Clinical Weakness in a Patient with Pilocytic Astrocytoma , Chicago, IL: 2023

Duque L, Ospina JP, Savica R, Philbrick K, Port JD, Singh B Characterization of Brain FDGPET Findings in Patients with Catatonia: A Case Series , Boston, MA: 2023

Ospina, JP, Park, DM Craniopharyngioma , Neuro-Oncology, MedLink Neurology: 20220

Duque L, Ospina JP, Philbrick K Manic Episode as a Manifestation of Recurrent Primary Central Nervous System Lymphoma with Intravascular Involvement , Atlanta, GA: 2022

Duque L, Ospina JP, Philbrick K, Singh B Functional Neuroimaging in Patients with Catatonia: A Systematic Review , New Orleans, LA: 2022

Duque L, Ospina JP, Singh B Mixed Affective Episode as Initial Manifestation of Glioblastoma Multiforme , Cartagena, Colombia: 2022